#SalivaDirect — the innovative, fast, non-invasive, and cheap testing method developed by Yale School of Public Health researchers with the help of the NBA — is expanding. Along with Yale Pathology Labs, three independent labs in Florida, Minnesota, and New York now represent the initial wave of designated providers. “After discovering saliva is a promising sample type for SARS-CoV-2 detection, we have made it our mission to develop a testing method that is accurate, affordable, and accessible to all," says Anne Wyllie, one of the leaders of the research team. "Our hope is that eventually every person that needs a COVID-19 test will be able to get one. Our laboratory partners are instrumental in ensuring schools and other essential institutions can remain open and healthy." Pictured is Christina Harden, a post-graduate researcher in the Grubaugh Lab, working on SalivaDirect™ tests. 🔗 Learn more through our link in bio